Windtree Therapeutics, Inc.
WINT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $16 | $8 | $11 | $18 |
| G&A Expenses | $9 | $0 | $11 | $14 |
| SG&A Expenses | $9 | $9 | $11 | $14 |
| Sales & Mktg Exp. | $0 | $9 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | -$1 | -$1 |
| Operating Expenses | $25 | $17 | $20 | $31 |
| Operating Income | -$25 | -$18 | -$41 | -$77 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $23 | -$3 | $1 | -$45 |
| Pre-Tax Income | -$2 | -$20 | -$41 | -$78 |
| Tax Expense | $4 | $0 | -$1 | -$10 |
| Net Income | -$5 | -$20 | -$39 | -$68 |
| % Margin | – | – | – | – |
| EPS | -104.35 | -4,711.54 | -56,011 | -122,924 |
| % Growth | 97.8% | 91.6% | 54.4% | – |
| EPS Diluted | -104.35 | -4,711.54 | -56,011 | -122,924 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $1 |
| EBITDA | -$1 | -$20 | -$39 | -$77 |
| % Margin | – | – | – | – |